Literature DB >> 15918109

Pericytes and the pathogenesis of diabetic retinopathy.

H-P Hammes1.   

Abstract

Incipient diabetic retinopathy is characterized by increased vascular permeability and progressive vascular occlusion. Pericyte loss precedes capillary occlusion in the diabetic retina, but its cause remains unclear. One concept proposes that pericyte loss is the result of toxic product accumulation and induction of destructive cellular signals generated within the pericyte. Alternatively, new experimental data indicate that pericyte dropout may result from regulations which induce pericyte elimination as an active process. Pericytes are critical for the development of a proper retinal network, and appear protective for endothelial cells under hyperglycemic conditions. The unifying hypothesis of hyperglycemia-induced microvascular damage centers around hyperglycemia-induced mitochondrial overproduction of reactive oxygen species. The pharmacological prevention of acellular capillaries without the rescue of pericyte loss in experimental diabetic retinopathy suggests that the endothelium is the primary therapeutic target.

Entities:  

Mesh:

Year:  2005        PMID: 15918109     DOI: 10.1055/s-2005-861361

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  83 in total

Review 1.  Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization.

Authors:  Amber N Stratman; George E Davis
Journal:  Microsc Microanal       Date:  2011-12-14       Impact factor: 4.127

Review 2.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes.

Authors:  Renu A Kowluru; Qing Zhong; Mamta Kanwar
Journal:  Exp Eye Res       Date:  2010-02-17       Impact factor: 3.467

4.  Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes.

Authors:  J L Barth; Y Yu; W Song; K Lu; A Dashti; Y Huang; W S Argraves; T J Lyons
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

5.  Response of rat retinal capillary pericytes and endothelial cells to glucose.

Authors:  Jun Makita; Ken-ichi Hosoya; Peng Zhang; Peter F Kador
Journal:  J Ocul Pharmacol Ther       Date:  2010-11-20       Impact factor: 2.671

6.  Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state.

Authors:  Matthew E Kutcher; Alexey Y Kolyada; Howard K Surks; Ira M Herman
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

7.  The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy.

Authors:  Yan-Ni Zhu; Guo-Jin Zuo; Qi Wang; Xiao-Ming Chen; Jin-Kui Cheng; Shu Zhang
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

8.  Static mechanical strain induces capillary endothelial cell cycle re-entry and sprouting.

Authors:  A S Zeiger; F D Liu; J T Durham; A Jagielska; R Mahmoodian; K J Van Vliet; I M Herman
Journal:  Phys Biol       Date:  2016-08-16       Impact factor: 2.583

9.  Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway.

Authors:  Pedro Geraldes; Kunimasa Yagi; Yuzuru Ohshiro; Zhiheng He; Yasuhiro Maeno; Junko Yamamoto-Hiraoka; Christian Rask-Madsen; Su Wol Chung; Mark A Perrella; George L King
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

10.  TGFβ induces BIGH3 expression and human retinal pericyte apoptosis: a novel pathway of diabetic retinopathy.

Authors:  B S Betts-Obregon; A A Mondragon; A S Mendiola; R G LeBaron; R Asmis; T Zou; F Gonzalez-Fernandez; A T Tsin
Journal:  Eye (Lond)       Date:  2016-08-26       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.